The importance of green chemistry in process research and development.

Green Chemistry or Sustainable Chemistry is defined by the Environmental Protection Agency as "the design of chemical products that reduce or eliminate the use of hazardous substances" In recent years there is a greater societal expectation that chemists and chemical engineers should produce greener and more sustainable chemical processes and it is likely that this trend will continue to grow over the next few decades. This tutorial review gives information on solvents and solvent selection, basic environmental metrics collection and three industrial case histories. All three case histories involve enzymatic chemistry. Pregabalin (Lyrica®) is produced using a lipase based resolution and is extremely unusual in that all four manufacturing steps to make pregabalin are performed in water. Sitagliptin (Januvia®) uses a transaminase in the final chemical step. Finally a rosuvastatin (Crestor®) intermediate is produced using a deoxy ribose aldolase (DERA) enzyme in which two carbon-carbon bonds and two chiral centres are formed in the same process step.

[1]  T. Graedel,et al.  In-use stocks of metals: status and implications. , 2008, Environmental science & technology.

[2]  John C Whitman,et al.  Improving catalytic function by ProSAR-driven enzyme evolution , 2007, Nature Biotechnology.

[3]  Geraldine Patricia Taber,et al.  A New and Simplified Process for Preparing N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine and a Telescoped Process for the Synthesis of (1S-cis)-4-(3,4-Dichlorophenol)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine Mandelate: Key Intermediates in the Synthesis of Sertraline , 2004 .

[4]  F. Arnold,et al.  Directed evolution of enzyme catalysts. , 1997, Trends in biotechnology.

[5]  T. Graedel,et al.  Metal stocks and sustainability , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. G. Mattingly,et al.  Synthesis of .beta.-lactams from substituted hydroxamic acids , 1980 .

[7]  D. H. Peterson,et al.  MICROBIOLOGICAL OXYGENATION OF STEROIDS AT CARBON 11 , 1952 .

[8]  O. Repič,et al.  The Story of Lescol: From Research to Production† , 2001 .

[9]  Peter J. Dunn,et al.  Green chemistry tools to influence a medicinal chemistry and research chemistry based organisation , 2008 .

[10]  C. Martínez,et al.  The Development of a Green, Energy Efficient, Chemoenzymatic Manufacturing Process for Pregabalin , 2010 .

[11]  W. Stemmer.  Rapid evolution of a protein in vitro by DNA shuffling , 1994, Nature.

[12]  B. Trost,et al.  The atom economy--a search for synthetic efficiency. , 1991, Science.

[13]  Feng Xu,et al.  Highly efficient asymmetric synthesis of sitagliptin. , 2009, Journal of the American Chemical Society.

[14]  Christian Capello,et al.  What is a green solvent? A comprehensive framework for the environmental assessment of solvents , 2007 .

[15]  A. Wells,et al.  Future Trends for Green Chemistry in the Pharmaceutical Industry , 2010 .

[16]  P. Anastas,et al.  Green Chemistry , 2018, Environmental Science.

[17]  Manfred T Reetz,et al.  Directed evolution of enantioselective enzymes: iterative cycles of CASTing for probing protein-sequence space. , 2006, Angewandte Chemie.

[18]  Andreas Schmid,et al.  The production of fine chemicals by biotransformations. , 2002, Current opinion in biotechnology.

[19]  R. Pohl,et al.  Pregabalin: a new anxiolytic , 2003, Expert opinion on investigational drugs.

[20]  Alan Millar,et al.  The synthesis of (4R-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate, a key intermediate for the preparation of CI-981, a highly potent, tissue selective inhibitor of HMG-CoA reductase , 1992 .

[21]  C. Wandrey,et al.  Highly Regio- and Enantioselective Reduction of 3,5-Dioxocarboxylates. , 2000, Angewandte Chemie.

[22]  Paul N. Devine,et al.  Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture , 2010, Science.

[23]  B. Roth,et al.  Contemporary Drug Synthesis: Li/Drug Synthesis , 2004 .

[24]  R. A. Jennings,et al.  An enantioselective synthesis of (S)-(+)-3-aminomethyl-5-methylhexanoic acid via asymmetric hydrogenation. , 2003, The Journal of organic chemistry.

[25]  Chi‐Huey Wong,et al.  Deoxyribose 5-phosphate aldolase as a catalyst in asymmetric aldol condensation , 1992 .

[26]  Roger A. Sheldon,et al.  The E Factor: fifteen years on , 2007 .

[27]  Junhua Tao,et al.  Recent applications of biocatalysis in developing green chemistry for chemical synthesis at the industrial scale , 2008 .

[28]  Daniel Mink,et al.  Directed evolution of an industrial biocatalyst: 2-deoxy-D-ribose 5-phosphate aldolase. , 2006, Biotechnology journal.

[29]  David J. C. Constable,et al.  Perspective on Solvent Use in the Pharmaceutical Industry , 2007 .

[30]  Junhua Tao,et al.  Development of a Chemoenzymatic Manufacturing Process for Pregabalin , 2008 .

[31]  J. Tao,et al.  Automated Enzyme Screening Methods for the Preparation of Enantiopure Pharmaceutical Intermediates , 2003 .

[32]  Peter J. Dunn,et al.  Green chemistry in the pharmaceutical industry , 2010 .

[33]  James H. Clark,et al.  Green chemistry: challenges and opportunities , 1999 .

[34]  John H. Grate,et al.  A green-by-design biocatalytic process for atorvastatin intermediate , 2010 .

[35]  Ramesh N. Patel,et al.  Enantioselective microbial reduction of 3,5-dioxo-6-(benzyloxy) hexanoic acid, ethyl ester , 1993 .

[36]  M. Hoekstra,et al.  Chemical Development of CI-1008, an Enantiomerically Pure Anticonvulsant , 1997 .

[37]  M. V. Filho,et al.  Chemoenzymatic synthesis of the chiral side-chain of statins: application of an alcohol dehydrogenase catalysed ketone reduction on a large scale , 2008, Bioprocess and biosystems engineering.

[38]  Che-Chang Hsu,et al.  Sequential aldol condensation catalyzed by DERA mutant Ser238Asp and a formal total synthesis of atorvastatin , 2004 .

[39]  Chi-Huey Wong,et al.  Unprecedented Asymmetric Aldol Reactions with Three Aldehyde Substrates Catalyzed by 2-Deoxyribose-5-phosphate Aldolase , 1994 .

[40]  S. Pines.  The Merck Bile Acid Cortisone Process: The Next-to-Last Word , 2004 .

[41]  Concepción Jiménez-González,et al.  Expanding GSK’s Solvent Selection Guide—application of life cycle assessment to enhance solvent selections , 2004 .

[42]  R. Noyori.  Insight: Green chemistry: the key to our future , 2010 .

[43]  Reid Lifset,et al.  Dining at the periodic table: metals concentrations as they relate to recycling. , 2007, Environmental science & technology.

[44]  J. Li.  Contemporary Drug Synthesis , 2004 .

[45]  D. Dess,et al.  Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones , 1983 .

[46]  D. W. Brooks,et al.  C‐Acylation under Virtually Neutral Conditions , 1979 .

[47]  Dipeptidyl peptidase IV inhibitors for the treatment of diabetes. , 2004, Journal of medicinal chemistry.

[48]  Chi‐Huey Wong,et al.  Recombinant 2-Deoxyribose-5-phosphate Aldolase in Organic Synthesis: Use of Sequential Two-Substrate and Three-Substrate Aldol Reactions , 1995 .